État de mal asthmatique : Questions médicales fréquentes
Nom anglais: Status Asthmaticus
Descriptor UI:D013224
Tree Number:C20.543.480.680.095.880
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "État de mal asthmatique : Questions médicales les plus fréquentes",
"headline": "État de mal asthmatique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les État de mal asthmatique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-24",
"dateModified": "2025-03-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "État de mal asthmatique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Asthme",
"url": "https://questionsmedicales.fr/mesh/D001249",
"about": {
"@type": "MedicalCondition",
"name": "Asthme",
"code": {
"@type": "MedicalCode",
"code": "D001249",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.480.680.095"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "État de mal asthmatique",
"alternateName": "Status Asthmaticus",
"code": {
"@type": "MedicalCode",
"code": "D013224",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kavipriya Komeswaran",
"url": "https://questionsmedicales.fr/author/Kavipriya%20Komeswaran",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Southern Illinois University School of Medicine, Springfield, Illinois, United Sates."
}
},
{
"@type": "Person",
"name": "Peter N Johnson",
"url": "https://questionsmedicales.fr/author/Peter%20N%20Johnson",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, OK, United States."
}
},
{
"@type": "Person",
"name": "Neha Gupta",
"url": "https://questionsmedicales.fr/author/Neha%20Gupta",
"affiliation": {
"@type": "Organization",
"name": "Division of Critical Care Medicine, Department of Pediatrics, University of Oklahoma College of Medicine, Oklahoma City, OK, United States."
}
},
{
"@type": "Person",
"name": "Timothy M Maul",
"url": "https://questionsmedicales.fr/author/Timothy%20M%20Maul",
"affiliation": {
"@type": "Organization",
"name": "Department of Cardiovascular Services, Nemours Children's Hospital, Orlando, FL."
}
},
{
"@type": "Person",
"name": "Jennifer S Nelson",
"url": "https://questionsmedicales.fr/author/Jennifer%20S%20Nelson",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Surgery, University of Central Florida College of Medicine, Orlando, FL."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Early Intravenous Magnesium Sulfate Administration in the Emergency Department for Severe Asthma Exacerbations.",
"datePublished": "2023-01-08",
"url": "https://questionsmedicales.fr/article/36728409",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/PEC.0000000000002890"
}
},
{
"@type": "ScholarlyArticle",
"name": "Safe and Effective Use of Score-Based Continuous Albuterol Therapy in a Pathway for Treatment of Pediatric Asthma Exacerbation.",
"datePublished": "2022-08-09",
"url": "https://questionsmedicales.fr/article/35944965",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4187/respcare.10083"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nebulizer versus metered dose inhaler with space chamber (MDI spacer) for acute asthma and chronic obstructive pulmonary disease exacerbation: attitudes of patients and healthcare providers in the COVID-19 era.",
"datePublished": "2022-06-07",
"url": "https://questionsmedicales.fr/article/35608065",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/02770903.2022.2082307"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of a loading dose of IV salbutamol in children with severe acute asthma admitted to a PICU: a randomized controlled trial.",
"datePublished": "2022-08-03",
"url": "https://questionsmedicales.fr/article/35922522",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00431-022-04576-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optimising intravenous salbutamol in children: a phase 2 study.",
"datePublished": "2022-12-29",
"url": "https://questionsmedicales.fr/article/36581395",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/archdischild-2022-324008"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hypersensibilité",
"item": "https://questionsmedicales.fr/mesh/D006967"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypersensibilité immédiate",
"item": "https://questionsmedicales.fr/mesh/D006969"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hypersensibilité respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012130"
},
{
"@type": "ListItem",
"position": 6,
"name": "Asthme",
"item": "https://questionsmedicales.fr/mesh/D001249"
},
{
"@type": "ListItem",
"position": 7,
"name": "État de mal asthmatique",
"item": "https://questionsmedicales.fr/mesh/D013224"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : État de mal asthmatique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur État de mal asthmatique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-30",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur État de mal asthmatique",
"description": "Comment diagnostiquer un état de mal asthmatique ?\nQuels signes indiquent un état de mal asthmatique ?\nQuels examens sont nécessaires pour le diagnostic ?\nComment évaluer la gravité de l'asthme ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D013224?page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur État de mal asthmatique",
"description": "Quels sont les symptômes principaux de l'état de mal asthmatique ?\nComment se manifeste la dyspnée dans cet état ?\nY a-t-il des symptômes atypiques à surveiller ?\nLes symptômes peuvent-ils varier selon les patients ?\nQuand faut-il consulter un médecin pour des symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D013224?page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur État de mal asthmatique",
"description": "Comment prévenir un état de mal asthmatique ?\nQuel rôle joue l'éducation des patients ?\nComment utiliser un plan d'action pour l'asthme ?\nLes vaccinations sont-elles importantes pour les asthmatiques ?\nComment gérer l'asthme en période de pollens ?",
"url": "https://questionsmedicales.fr/mesh/D013224?page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur État de mal asthmatique",
"description": "Quels traitements sont utilisés pour l'état de mal asthmatique ?\nComment administrer les bronchodilatateurs en urgence ?\nQuel est le rôle des corticostéroïdes ?\nQuand utiliser l'oxygénothérapie ?\nQuels sont les traitements de suivi après une crise ?",
"url": "https://questionsmedicales.fr/mesh/D013224?page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur État de mal asthmatique",
"description": "Quelles complications peuvent survenir avec l'état de mal asthmatique ?\nComment l'état de mal asthmatique affecte-t-il la qualité de vie ?\nY a-t-il un risque de décès lié à cet état ?\nComment prévenir les complications à long terme ?\nLes complications peuvent-elles affecter d'autres organes ?",
"url": "https://questionsmedicales.fr/mesh/D013224?page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur État de mal asthmatique",
"description": "Quels sont les principaux facteurs de risque de l'état de mal asthmatique ?\nLe stress peut-il aggraver l'asthme ?\nComment l'environnement influence-t-il l'asthme ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes infections virales sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D013224?page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un état de mal asthmatique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique et des tests de fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un état de mal asthmatique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent dyspnée sévère, respiration sifflante et incapacité à parler."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens comme la spirométrie et la mesure du débit expiratoire sont essentiels."
}
},
{
"@type": "Question",
"name": "Comment évaluer la gravité de l'asthme ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gravité est évaluée par les symptômes, la fonction pulmonaire et la réponse au traitement."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier les déclencheurs et les antécédents d'exacerbations."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux de l'état de mal asthmatique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une respiration rapide, une toux persistante et une cyanose."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la dyspnée dans cet état ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dyspnée est intense et peut rendre la parole difficile ou impossible."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes atypiques à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue extrême ou des douleurs thoraciques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier selon les patients ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la sévérité de l'asthme."
}
},
{
"@type": "Question",
"name": "Quand faut-il consulter un médecin pour des symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes s'aggravent ou ne répondent pas au traitement habituel."
}
},
{
"@type": "Question",
"name": "Comment prévenir un état de mal asthmatique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les déclencheurs connus et suivez un traitement préventif régulier."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'éducation des patients ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation aide les patients à reconnaître les signes d'alerte et à gérer leur asthme."
}
},
{
"@type": "Question",
"name": "Comment utiliser un plan d'action pour l'asthme ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un plan d'action décrit les étapes à suivre en cas d'aggravation des symptômes."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes pour les asthmatiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations contre la grippe et le pneumocoque sont recommandées."
}
},
{
"@type": "Question",
"name": "Comment gérer l'asthme en période de pollens ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Restez à l'intérieur pendant les pics de pollen et utilisez des antihistaminiques si nécessaire."
}
},
{
"@type": "Question",
"name": "Quels traitements sont utilisés pour l'état de mal asthmatique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des bronchodilatateurs, des corticostéroïdes et l'oxygénothérapie."
}
},
{
"@type": "Question",
"name": "Comment administrer les bronchodilatateurs en urgence ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bronchodilatateurs sont souvent administrés par inhalation ou nébulisation."
}
},
{
"@type": "Question",
"name": "Quel est le rôle des corticostéroïdes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes réduisent l'inflammation et améliorent la fonction pulmonaire rapidement."
}
},
{
"@type": "Question",
"name": "Quand utiliser l'oxygénothérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'oxygénothérapie est utilisée lorsque la saturation en oxygène est inférieure à 92%."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements de suivi après une crise ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi avec des médicaments de contrôle et un plan d'action est essentiel après une crise."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'état de mal asthmatique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance respiratoire et les infections pulmonaires."
}
},
{
"@type": "Question",
"name": "Comment l'état de mal asthmatique affecte-t-il la qualité de vie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut entraîner des limitations dans les activités quotidiennes et des absences scolaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de décès lié à cet état ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un état de mal asthmatique non traité peut être fatal, nécessitant une attention urgente."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier et un traitement adéquat sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter d'autres organes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hypoxie peut affecter le cœur et d'autres organes, entraînant des complications systémiques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de l'état de mal asthmatique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des allergènes, le tabagisme et des infections respiratoires."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver l'asthme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress émotionnel et physique peut déclencher des exacerbations d'asthme."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il l'asthme ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs environnementaux comme la pollution et les changements climatiques peuvent aggraver l'asthme."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial d'asthme augmente le risque de développer cette maladie."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections virales, surtout chez les jeunes enfants, peuvent déclencher des crises."
}
}
]
}
]
}
Severe asthma exacerbations in pediatric patients occur frequently and can require pediatric intensive care unit (PICU) admission....
To determine if early administration of intravenous magnesium sulfate (IVMg) to pediatric patients experiencing severe asthma exacerbations, defined as a respiratory clinical score (RCS) of 9 to 12, r...
Retrospective chart review of pediatric patients aged from 2 to 17 years presenting with a severe asthma exacerbation to a single tertiary care pediatric emergency department. Univariable and multivar...
A total of 1911 patients were included in the study, of which 1541 received IVMg. The average time to IVMg was 79 minutes, with 35% of the patients receiving it within 60 minutes of arrival. Two hundr...
Early administration of IVMg to pediatric patients experiencing severe asthma exacerbations does not result in fewer PICU admissions....
Standardized acute asthma management with score-based, respiratory therapist (RT)-driven pathways and protocols improves outcomes including decreased length of stay (LOS) and time on continuous albute...
A retrospective review of children ≥ 2 y admitted for asthma exacerbation to the PICU and step-down unit who received continuous albuterol as part of the asthma pathway during 2017-2019 was completed....
Results are expressed as median (interquartile range). The study included 412 children (61% male, 59.9% Black, 92.7% non-Hispanic, 44.9% moderate persistent asthma) with age and weight of 6.4 (4.0-10....
Use of an RT-driven, score-based pathway for initiation and discontinuation of continuous albuterol for treatment of pediatric asthma exacerbation was safe and effective in the PICU and step-down unit...
Short-acting bronchodilators for asthma and chronic obstructive pulmonary disease (COPD) exacerbations are commonly delivered by nebulizers although administration using metered dose inhaler with spac...
Patients admitted for asthma or COPD exacerbations, doctors, and nurses in a university-affiliated hospital were surveyed from 1 April 2021 to 30 September 2021 regarding their views on the effectiven...
Ninety-nine patients, 103 doctors, and 650 nurses completed the survey. 60.6% of patients perceived nebulizer to be more effective. Patients who found nebulizer more comfortable were more likely to pr...
Patients and healthcare providers perceived nebulizer to be more effective. Factors unique to each group influenced their preference for nebulizer....
The optimal dose regimen for intravenous (IV) treatment in children with severe acute asthma (SAA) is still a matter of debate. We assessed the efficacy of adding a salbutamol loading dose to continuo...
We found no clinical benefit of adding a loading dose IV salbutamol to continuous infusion of salbutamol, in children admitted to the PICU with SAA. Clinically significant side effects from the loadin...
• Pediatric asthma guidelines struggle with an evidence-based approach for the treatment of SAA beyond the initial steps of oxygen suppletion, repetitive administration of inhaled β2-agonists, and sys...
• This study found no beneficial effect of an additional loading dose IV salbutamol in children admitted to the PICU. • This study found no clinically significant side effects from the loading dose....
The β2-agonists such as salbutamol are the mainstay of asthma management. Pharmacokinetic-pharmacodynamic (PKPD) models to guide paediatric dosing are lacking. We explored the relationship between sal...
A prospective cohort study of children admitted to hospital with acute asthma, who received intravenous salbutamol....
Children were recruited in two cohorts: the emergency departments of two London hospitals or those retrieved by the Children's Acute Transport Service to three London paediatric intensive care units....
Patients were eligible if aged 1-15 years, admitted for acute asthma and about to receive or receiving intravenous salbutamol....
Treatment was according to local policy. Serial salbutamol plasma levels were taken. Effectiveness measurements were recorded using the Paediatric Asthma Severity Score (PASS). Toxicity measurements i...
Fifty-eight children were recruited with 221 salbutamol concentration measurements from 54 children. Median (range) age was 2.9 (1.1-15.2) years, and weight was 13.6 (8-57.3) kg. Ninety-five PASS meas...
A two-compartment PK model adequately described the time course of salbutamol-plasma concentrations. An E...
A paediatric PKPD model for salbutamol is described. An infusion of 0.5 µg/kg/min after bolus achieves effective bronchodilation. Higher rates are associated with greater tachycardia and hyperglycaemi...
Patients with severe uncontrolled asthma still experience acute asthma symptoms and exacerbations, particularly those with non-eosinophilic inflammation who take the maximum amount of standard drug th...
Treatment of primary prostate cancer extremely depends on preoperative stage. The role of...
In this retrospective study, all patients with prostate cancer who underwent mpMRI and...
Ultimately, 130 patients were included in this study. In the preoperative judgment of EPE and SVI, mpMRI + PSMA-PET/CT had higher sensitivity and specificity. When predicting lymph node metastasis, PS...
Based on the combined results of mpMRI and...
European mistletoe,...
Nine mistletoe-host pairs (i.e....
There were only non-significant relationships between NSC concentrations in mistletoe and in its host species across the nine mistletoe-host pairs, suggesting the carbon condition of...
Status hierarchies are ubiquitous across cultures and have been over deep time. Position in hierarchies shows important links with fitness outcomes. Consequently, humans should possess psychological a...
Subjective "ladder" measurements of socio-economic status (SES) are easy-to-administer tools that ask respondents to rate their own SES, allowing them to evaluate their own material resources and dete...
Leveraging a study of 595 tuberculosis patients in Lima, Peru, we compared the MacArthur ladder score to the WAMI score using weighted Kappa scores and Spearman's rank correlation coefficient. We iden...
The correlation coefficient between the MacArthur ladder and WAMI scores was 0.37 and the weighted Kappa was 0.26. The correlation coefficients differed by less than 0.04 and the Kappa ranged from 0.2...
Our findings demonstrated fair agreement between the MacArthur ladder and WAMI scores. The agreement between the two SES measurements increased when they were further categorized into 3-5 categories, ...